Consistently, we found a significant reduction in tumor growth and increased levels of BRCA1 and RAD17 in xenografted tumors arising from the HNSCC CAL27 cell line, orthotopically and intrascapularly injected in immunocompromised mice and subsequently treated with miR-205-5p synthetic inhibitors. This evidence concerns the gene BRCA1 and neoplasm.